CN[C@@H]1[C@H](O)[C@@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]2[C@H](NC)[C@@H]1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?